1. Preoperative Radiographic Predictors of Subsequent Fusion After Lumbar Decompression Surgery.
- Author
-
Lambrechts MJ, Heard JC, D'Antonio ND, Lee Y, Narayanan R, Ezeonu T, Breyer G, Paulik J, Somers S, Labarbiera AJ, Canseco JA, Kurd MF, Kaye ID, Hilibrand AS, Vaccaro AR, Schroeder GD, and Kepler CK
- Subjects
- Humans, Male, Female, Middle Aged, Retrospective Studies, Aged, Adult, Radiography methods, Risk Factors, Decompression, Surgical methods, Lumbar Vertebrae surgery, Lumbar Vertebrae diagnostic imaging, Spinal Fusion methods, Lordosis surgery, Lordosis diagnostic imaging
- Abstract
Study Design: Retrospective cohort study., Objective: The purpose of this study is to determine which demographic, surgical, and radiographic preoperative characteristics are most associated with the need for subsequent fusion after decompression lumbar spinal surgery., Summary of Background Data: There is a relatively high rate of the need for repeat decompression or fusion after an index decompression procedure for degenerative spine disease. Nevertheless, there is a dearth of literature identifying risk factors for lumbar fusion following decompression surgery., Methods: Patients 18 years or older receiving a primary lumbar decompression surgery within the levels of L3-S1 between 2011 and 2020 were identified. All patients had preoperative radiographs and 2 years of follow-up data. Chart review was performed for surgical characteristics and demographics. The sagittal parameters included lumbar lordosis (LL), segmental lordosis (SL), anterior disk height (aDH), posterior disk height (pDH), sacral slope (SS), and pelvic tilt (PT). Pelvic incidence (PI=PT+SS) and pelvic incidence minus lumbar lordosis (PI-LL) were calculated. In addition, the Roussouly classification was determined for each patient. Bivariant and multivariant analyses were performed., Results: Of the 363 patients identified in this study, 96 patients had a fusion after their index decompression surgery. Multivariable analysis identified involvement of L4-L5 level in the decompression [odds ratio (OR)=1.83 (1.09-3.14), P =0.026], increased L5-S1 segmental lordosis [OR=1.08 (1.03-1.13), P =0.001], decreased SS [OR=0.96 (0.93-0.99), P =0.023], and decreased endplate obliquity [OR=0.88 (0.77-0.99), P =0.040] as significant independent predictors of fusion after decompression surgery., Conclusions: This is one of the first studies to assess preoperative sagittal parameters in conjunction with demographic variables to determine predictors of the need for fusion after index decompression. We demonstrated that decompression at L4-L5, greater L5-S1 segmental lordosis, decreased sacral slope, and decreased endplate obliquity were associated with higher rates of fusion after decompression surgery., Competing Interests: M.J.L. serves as on the editorial or governing board of BMC Musculoskeletal Disorders and Wolters Kluwer Health—Lippincott Williams & Wilkins. J.A.C. serves as a board/committee member for the Clinical Spine Research Society and has stock/stock options in PathKeeper Surgical. He receives research support from Accelus. M.F.K. is a paid consultatnt for Camber Spine and Spinal Elements. He has received royalty payments from Spinal Elements and Stryker and maintains stock or stock options with DuraStat LLC. I.D.K. is a paid consultant for Johnson & Johnson and Nuvasive. He receives research support from Camber Spine, as well as other financial support from Thieme. He serves on the board of the North American Spine Society and Spinal Cord and Case Series. A.S.H. receives royalties from Biomet and CTL Amedica and has stock or stock options with Paradigm Spine. A.R.V. serves as a board/committee member of the National Spine Health Foundation. He has received royalty payments from Medtronic, Stryker Spine, Globus, Aesculap, Thieme, Jaypee, Elsevier, and Taylor Francis/Hodder and Stoughton. He has stock/stock option ownership interests in Replication Medica, Globus, Paradigm Spine, Stout Medical, Progressive Spinal Technologies, Advanced Spinal Intellectual Properties, Spine Medica, Computational Biodynamics, Spinology, In Vivo, Flagship Surgical, Cytonics, Bonovo Orthopaedics, Electrocore, Gamma Spine, Location Based Intelligence, FlowPharma, R.S.I., Rothman Institute and Related Properties, Innovative Surgical Design, and Avaz Surgical. He has also served as deputy editor/editor of Spine. In addition, A.R.V. has also provided expert testimony. He has also served as deputy editor/editor of Clinical Spine Surgery. G.D.S. is a paid consultant for Advance Medical, Bioventus, and Surgalign. He serves on the board of Clinical Spine Surgery, AO Spine, Cervical Spine Research Society, and Wolters Kluwer Health—Lippincott Williams & Wilkins. He receives research support from Cerapedics, DePuy, A Johnson and Johnson Company, and Medtronic Sofamor Danek. C.K.K. serves on the editorial board of Clinical Spine Surgery and receives royalties from Curetiva and Regeneration Technologies Inc. The remaining authors report no conflicts of interest, (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF